Guillermo Chantada Selected Research

N-glycolylneuraminyllactosylceramide (HD3)

6/2015	Immunoreactivity of the 14F7 Mab raised against N-Glycolyl GM3 Ganglioside in retinoblastoma tumours.
1/2011	Detection of N-glycolyl GM3 ganglioside in neuroectodermal tumors by immunohistochemistry: an attractive vaccine target for aggressive pediatric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guillermo Chantada Research Topics

Disease

21	Retinoblastoma (Glioblastoma, Retinal) 01/2022 - 07/2007
18	Neoplasms (Cancer) 01/2022 - 07/2007
6	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2021
3	Neuroblastoma 01/2022 - 01/2011
2	COVID-19 10/2022 - 01/2021
2	Leukemia 01/2022 - 07/2007
2	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 11/2020
2	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 01/2021 - 01/2016
2	Melanoma (Melanoma, Malignant) 11/2020 - 01/2011
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2022
1	Orbital Cellulitis 01/2022
1	Hemorrhage 01/2022
1	Glaucoma 01/2022
1	Sclerosing Cholangitis 01/2021
1	Margins of Excision 01/2021
1	Cholestasis 01/2021
1	Cytomegalovirus Infections (Inclusion Disease) 01/2021
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Malnutrition (Nutritional Deficiencies) 01/2021
1	Febrile Neutropenia 01/2021
1	Leiomyosarcoma 11/2020
1	Central Nervous System Neoplasms 11/2020
1	Hydrophthalmos 11/2019
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019
1	Anaphylaxis (Anaphylactic Shock) 02/2018
1	Retinal Hemorrhage 02/2018
1	Hypotension (Low Blood Pressure) 02/2018
1	Bradycardia 02/2018
1	Thrombosis (Thrombus) 02/2018
1	Alopecia (Baldness) 02/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2011
1	Breast Neoplasms (Breast Cancer) 01/2011
1	Neuroectodermal Tumors (Neuroectodermal Tumor) 01/2011
1	Hypoalbuminemia 05/2010
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2007

Drug/Important Bio-Agent (IBA)

4	Topotecan (Hycamtin)FDA LinkGeneric 12/2018 - 07/2010
3	Biological ProductsIBA 01/2021 - 08/2015
3	Pharmaceutical PreparationsIBA 01/2021 - 07/2010
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 01/2016
2	Melphalan (Alkeran)FDA LinkGeneric 12/2018 - 01/2016
2	Carboplatin (JM8)FDA LinkGeneric 12/2018 - 02/2018
2	N-glycolylneuraminyllactosylceramide (HD3)IBA 06/2015 - 01/2011
2	G(M3) GangliosideIBA 06/2015 - 01/2011
1	SuspensionsIBA 10/2022
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 07/2021
1	InterferonsIBA 01/2021
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2019
1	SurvivinIBA 12/2018
1	Ointments (Pastes)IBA 05/2017
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2016
1	Cladribine FDA LinkGeneric 01/2016
1	Vincristine (Oncovin)FDA LinkGeneric 01/2016
1	Prednisone (Sone)FDA LinkGeneric 01/2016
1	Monoclonal AntibodiesIBA 06/2015
1	GangliosidesIBA 01/2011
1	ParaffinIBA 01/2011
1	Formaldehyde (Formol)FDA Link 01/2011
1	VaccinesIBA 01/2011
1	AlbuminsIBA 05/2010
1	A-factor (Streptomyces)IBA 07/2007

Therapy/Procedure

20	Drug Therapy (Chemotherapy) 01/2022 - 07/2007
9	Therapeutics 01/2022 - 06/2015
5	Radiotherapy 01/2021 - 07/2007
3	Adjuvant Chemotherapy 01/2021 - 07/2007
2	Complementary Therapies (Alternative Medicine) 12/2017 - 05/2015
1	Salvage Therapy 01/2022
1	Conservative Treatment 07/2021
1	Personal Protective Equipment 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Liver Transplantation 01/2021
1	Brachytherapy 12/2020
1	Neoadjuvant Therapy 11/2019
1	Hand Hygiene 01/2019
1	Topical Administration 05/2017
1	Intravitreal Injections 01/2016
1	Immunotherapy 01/2011